The New ADHD Drug Carries Two Boxed Warnings and Will Be a Controlled Substance
The new ADHD drug Simtriyo carries two boxed warnings, pediatric suicidality monitoring, and CNS stimulant status pending DEA scheduling.
Medical Daily ·